vs
ARS Pharmaceuticals, Inc.（SPRY）与UNIVERSAL HEALTH REALTY INCOME TRUST（UHT）财务数据对比。点击上方公司名可切换其他公司
ARS Pharmaceuticals, Inc.的季度营收约是UNIVERSAL HEALTH REALTY INCOME TRUST的1.1倍（$28.1M vs $24.5M），UNIVERSAL HEALTH REALTY INCOME TRUST净利率更高（17.7% vs -147.1%，领先164.8%），UNIVERSAL HEALTH REALTY INCOME TRUST同比增速更快（-0.7% vs -67.6%）
ARS Pharmaceuticals是一家处于后期研发阶段的生物制药企业，专注于开发和商业化严重过敏反应创新疗法，核心产品为无需注射的肾上腺素鼻腔递送制剂，主要面向北美市场，服务存在致命过敏风险的成人及儿童患者群体。
环球健康服务公司（UHS）是一家总部位于宾夕法尼亚州普鲁士国王市的美国医疗服务企业，位列财富500强，主营医院运营及各类医疗保健服务。该公司2024年公布的总营收达158亿美元。
SPRY vs UHT — 直观对比
营收规模更大
SPRY
是对方的1.1倍
$24.5M
营收增速更快
UHT
高出66.9%
-67.6%
净利率更高
UHT
高出164.8%
-147.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $28.1M | $24.5M |
| 净利润 | $-41.3M | $4.3M |
| 毛利率 | — | — |
| 营业利润率 | -147.6% | 34.7% |
| 净利率 | -147.1% | 17.7% |
| 营收同比 | -67.6% | -0.7% |
| 净利润同比 | -182.8% | -7.2% |
| 每股收益（稀释后） | $-0.41 | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收SPRYUHT
| Q4 25 | $28.1M | $24.5M | ||
| Q3 25 | $32.5M | $25.3M | ||
| Q2 25 | $15.7M | $24.9M | ||
| Q1 25 | $8.0M | $24.5M | ||
| Q4 24 | $86.6M | $24.6M | ||
| Q3 24 | $2.1M | $24.5M | ||
| Q2 24 | $500.0K | $24.7M | ||
| Q1 24 | $0 | $25.1M |
净利润SPRYUHT
| Q4 25 | $-41.3M | $4.3M | ||
| Q3 25 | $-51.2M | $4.0M | ||
| Q2 25 | $-44.9M | $4.5M | ||
| Q1 25 | $-33.9M | $4.8M | ||
| Q4 24 | $49.9M | $4.7M | ||
| Q3 24 | $-19.1M | $4.0M | ||
| Q2 24 | $-12.5M | $5.3M | ||
| Q1 24 | $-10.3M | $5.3M |
营业利润率SPRYUHT
| Q4 25 | -147.6% | 34.7% | ||
| Q3 25 | -163.7% | 33.2% | ||
| Q2 25 | -302.9% | 35.6% | ||
| Q1 25 | -466.3% | 36.8% | ||
| Q4 24 | 54.5% | 37.6% | ||
| Q3 24 | -1051.6% | 34.7% | ||
| Q2 24 | -3068.0% | 38.7% | ||
| Q1 24 | — | 37.6% |
净利率SPRYUHT
| Q4 25 | -147.1% | 17.7% | ||
| Q3 25 | -157.4% | 15.9% | ||
| Q2 25 | -285.6% | 18.1% | ||
| Q1 25 | -425.7% | 19.5% | ||
| Q4 24 | 57.7% | 18.9% | ||
| Q3 24 | -925.0% | 16.3% | ||
| Q2 24 | -2503.2% | 21.3% | ||
| Q1 24 | — | 21.1% |
每股收益（稀释后）SPRYUHT
| Q4 25 | $-0.41 | $0.32 | ||
| Q3 25 | $-0.52 | $0.29 | ||
| Q2 25 | $-0.46 | $0.32 | ||
| Q1 25 | $-0.35 | $0.34 | ||
| Q4 24 | $0.52 | $0.34 | ||
| Q3 24 | $-0.20 | $0.29 | ||
| Q2 24 | $-0.13 | $0.38 | ||
| Q1 24 | $-0.11 | $0.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $245.0M | $6.7M |
| 总债务越低越好 | $96.4M | $374.8M |
| 股东权益账面价值 | $114.3M | $152.4M |
| 总资产 | $327.7M | $564.9M |
| 负债/权益比越低杠杆越低 | 0.84× | 2.46× |
8季度趋势，按日历期对齐
现金及短期投资SPRYUHT
| Q4 25 | $245.0M | $6.7M | ||
| Q3 25 | $288.2M | $6.9M | ||
| Q2 25 | $240.1M | $6.6M | ||
| Q1 25 | $275.7M | $7.0M | ||
| Q4 24 | $314.0M | $7.1M | ||
| Q3 24 | $204.6M | $6.4M | ||
| Q2 24 | $218.7M | $5.6M | ||
| Q1 24 | $223.6M | $7.7M |
总债务SPRYUHT
| Q4 25 | $96.4M | $374.8M | ||
| Q3 25 | $96.2M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $0 | $368.4M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益SPRYUHT
| Q4 25 | $114.3M | $152.4M | ||
| Q3 25 | $147.7M | $158.6M | ||
| Q2 25 | $192.3M | $165.2M | ||
| Q1 25 | $229.0M | $172.2M | ||
| Q4 24 | $256.8M | $179.5M | ||
| Q3 24 | $201.0M | $181.6M | ||
| Q2 24 | $215.2M | $190.7M | ||
| Q1 24 | $223.9M | $196.5M |
总资产SPRYUHT
| Q4 25 | $327.7M | $564.9M | ||
| Q3 25 | $372.8M | $568.0M | ||
| Q2 25 | $313.5M | $573.0M | ||
| Q1 25 | $327.3M | $573.5M | ||
| Q4 24 | $351.2M | $580.9M | ||
| Q3 24 | $217.6M | $584.3M | ||
| Q2 24 | $222.0M | $586.6M | ||
| Q1 24 | $227.6M | $596.2M |
负债/权益比SPRYUHT
| Q4 25 | 0.84× | 2.46× | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.00× | 2.05× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-43.5M | $49.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | 11.35× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流SPRYUHT
| Q4 25 | $-43.5M | $49.1M | ||
| Q3 25 | $-47.0M | $10.2M | ||
| Q2 25 | $-39.6M | $13.7M | ||
| Q1 25 | $-40.7M | $11.6M | ||
| Q4 24 | $42.0M | $46.9M | ||
| Q3 24 | $-14.5M | $9.9M | ||
| Q2 24 | $-7.3M | $12.1M | ||
| Q1 24 | $-6.7M | $11.7M |
自由现金流SPRYUHT
| Q4 25 | — | — | ||
| Q3 25 | $-47.2M | — | ||
| Q2 25 | $-39.6M | — | ||
| Q1 25 | $-40.8M | — | ||
| Q4 24 | $41.7M | — | ||
| Q3 24 | $-14.6M | — | ||
| Q2 24 | $-7.3M | — | ||
| Q1 24 | $-6.8M | — |
自由现金流率SPRYUHT
| Q4 25 | — | — | ||
| Q3 25 | -145.4% | — | ||
| Q2 25 | -252.2% | — | ||
| Q1 25 | -512.1% | — | ||
| Q4 24 | 48.2% | — | ||
| Q3 24 | -706.3% | — | ||
| Q2 24 | -1463.4% | — | ||
| Q1 24 | — | — |
资本支出强度SPRYUHT
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.6% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 1.1% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 6.8% | — | ||
| Q2 24 | 7.6% | — | ||
| Q1 24 | — | — |
现金转化率SPRYUHT
| Q4 25 | — | 11.35× | ||
| Q3 25 | — | 2.54× | ||
| Q2 25 | — | 3.05× | ||
| Q1 25 | — | 2.43× | ||
| Q4 24 | 0.84× | 10.06× | ||
| Q3 24 | — | 2.48× | ||
| Q2 24 | — | 2.30× | ||
| Q1 24 | — | 2.21× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
SPRY
| Products | $20.3M | 72% |
| Other | $7.8M | 28% |
UHT
| Reportable Segment Aggregation Before Other Operating Segment | $23.1M | 94% |
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | $2.3M | 9% |
